Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company is a contract manufacturer, manufactures and markets formulations for the pharmaceutical industry in India and internationally.
Windlas Biotech Limited, is a listed public company incorporated on 19 February, 2001. It is classified as a public limited company and is located in , Uttarakhand. It's authorized share capital is INR 77.50 cr and the total paid-up capital is INR 10.54 cr.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Pawan Kumar Sharma | 08478261 | 7 years |
| Director | Prachi Jain Windlass
Shareholder
|
06661073 | 5 years |
| Director | Srinivasan Venkataraman | 01132306 | 5 years |
| Director | Vivek Dhariwal | 02826679 | 5 years |
| Director | Gaurav Gulati | 02308392 | 5 years |
| Managing Director | Hitesh Windlass
Shareholder
|
02030941 | 18 years |
| Managing Director | Manoj Kumar Windlass
Shareholder
|
00221671 | 20 years |
| Whole-time Director | Ashok Kumar Windlass
Shareholder
|
00011451 | 25 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2025 available in Tofler Pro
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
The Hongkong and Shanghai Banking Corporation Limited
No. of Loans: 1
Total Amount : 40.0 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 23.3 cr
IndusInd Bank Limited
No. of Loans: 1
Total Amount : 10.0 cr
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| WINDLASS INC. | United States | - | - |
Read more
The incorporation date of WINDLAS BIOTECH LIMITED is 19 February, 2001
The authorized share capital of WINDLAS BIOTECH LIMITED is INR ₹ 77.5 Cr.
The paid-up capital of WINDLAS BIOTECH LIMITED is INR ₹ 10.5 Cr.
The registered address of WINDLAS BIOTECH LIMITED is 40/1 MOHABEWALA INDUSTRIAL AREA, DEHRADUN, Uttarakhand, India, 248110 - 248110
The CIN number of WINDLAS BIOTECH LIMITED is L74899UR2001PLC033407.